See today's BioWorld
To read the full story, subscribe or sign in.

On a back burner for decades, Potaba’s US approval finally to come to an end

March 9, 2022
By Mari Serebrov
After more than 50 years of trying, the U.S. FDA is finally withdrawing approval of Potaba (potassium aminobenzoate) tablets, capsules, powder, and other forms as well as any identical, related or similar products.
BioWorld Regulatory U.S. FDA